{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:49:22Z","timestamp":1792014562071,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360526"],"award-info":[{"award-number":["82360526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560579"],"award-info":[{"award-number":["82560579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2023GXNSFDA026011"],"award-info":[{"award-number":["2023GXNSFDA026011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"DOI":"10.1007\/s12072-026-11151-y","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:10:49Z","timestamp":1792012249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive evaluation on the impact of MASLD on the prognosis of chronic hepatitis B-related hepatocellular carcinoma following hepatectomy: results from retrospective multicenter cohort study and meta-analysis"],"prefix":"10.1007","author":[{"given":"Yiyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanneng","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2032an","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-2273","authenticated-orcid":false,"given":"Yihe","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"2","key":"11151_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s13277-015-3127-6","volume":"36","author":"X-J Lu","year":"2015","unstructured":"Lu X-J, Shi Y, Chen J-L, Ma S. Kr\u00fcppel-like factors in hepatocellular carcinoma. Tumor Biology. 2015;36(2):533\u2013541","journal-title":"Tumor Biology"},{"issue":"1","key":"11151_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/hepr.13583","volume":"51","author":"Y Eguchi","year":"2021","unstructured":"Eguchi Y, Wong G, Lee IH, Akhtar O, Lopes R, Sumida Y. Hepatocellular carcinoma and other complications of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: a structured review of published works. Hepatol Res. 2021;51(1):19\u201330","journal-title":"Hepatol Res"},{"issue":"4","key":"11151_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u2013238","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11151_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434\u2013438","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"11151_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2023-100019","volume":"1","author":"M Eslam","year":"2023","unstructured":"Eslam M, George J. Two years on, a perspective on MAFLD. eGastroenterology. 2023;1(2): e100019. https:\/\/doi.org\/10.1136\/egastro-2023-100019","journal-title":"eGastroenterology"},{"issue":"6","key":"11151_CR6","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"M Korenjak","year":"2023","unstructured":"Korenjak M, Tisthammer B, Xanthakos S, Chalasani N, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"11151_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1817642","volume":"17","author":"H Tao","year":"2026","unstructured":"Tao H, Duan Y, Yu G, Yan W, Yin J. Metabolic dysfunction-associated fatty liver disease in chronic hepatitis B: dual effects on hepatocarcinogenesis and evolving strategies for risk prediction. Front Immunol. 2026;17: 1817642. https:\/\/doi.org\/10.3389\/fimmu.2026.1817642","journal-title":"Front Immunol"},{"issue":"7","key":"11151_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma","year":"2017","unstructured":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169(7):1327-1341.e1323","journal-title":"Cell"},{"issue":"3","key":"11151_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3350\/cmh.2023.0004","volume":"29","author":"YJ Wong","year":"2023","unstructured":"Wong YJ, Nguyen VH, Yang HI, et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023;29(3):705\u2013720. https:\/\/doi.org\/10.3350\/cmh.2023.0004","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"11151_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101589","volume":"30","author":"S Hong","year":"2025","unstructured":"Hong S, Hao Y, Sun L, et al. Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease. Ann Hepatol. 2025;30(2): 101589","journal-title":"Ann Hepatol"},{"issue":"2","key":"11151_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70087","volume":"6","author":"H Zeng","year":"2025","unstructured":"Zeng H, Fang L, Yang Z, et al. Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population-based study. MedComm. 2025;6(2): e70087","journal-title":"MedComm"},{"issue":"1","key":"11151_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"1","key":"11151_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100485","volume":"65","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Sookoian S. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. J Lipid Res. 2024;65(1): 100485. https:\/\/doi.org\/10.1016\/j.jlr.2023.100485","journal-title":"J Lipid Res"},{"issue":"6","key":"11151_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","volume":"19","author":"JP Arab","year":"2020","unstructured":"Arab JP, Dirchwolf M, \u00c1lvares-da-Silva MR, et al. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. Ann Hepatol. 2020;19(6):674\u2013769","journal-title":"Ann Hepatol"},{"issue":"2","key":"11151_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","volume":"68","author":"M Boyle","year":"2018","unstructured":"Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver. J Hepatol. 2018;68(2):251\u2013267","journal-title":"J Hepatol"},{"key":"11151_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205002","author":"B Yun","year":"2022","unstructured":"Yun B, Ahn SH, Oh J, Yoon JH, Kim BK. Prognostic impact of MAFLD following surgical resection of hepatitis B virus-related hepatocellular carcinoma: a nationwide cohort study. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14205002","journal-title":"Cancers"},{"issue":"9","key":"11151_CR17","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.62347\/LJRG3048","volume":"14","author":"CN Huynh","year":"2024","unstructured":"Huynh CN, Tsai YC, Tsai MJ, et al. Impact of concurrent MASLD on early-stage HCC following curative resection in chronic hepatitis B. Am J Cancer Res. 2024;14(9):4567\u20134579","journal-title":"Am J Cancer Res"},{"issue":"7","key":"11151_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.hpb.2020.10.027","volume":"23","author":"YB Jung","year":"2021","unstructured":"Jung YB, Yoo JE, Han DH, et al. Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma. HPB (Oxford). 2021;23(7):1113\u20131122","journal-title":"HPB (Oxford)"},{"key":"11151_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1042869","volume":"12","author":"KJ Zhang","year":"2022","unstructured":"Zhang KJ, Ye TW, Lu WF, et al. Impact of metabolic syndrome on the long-term prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Front Oncol. 2022;12: 1042869","journal-title":"Front Oncol"},{"key":"11151_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.783339","volume":"11","author":"L Liu","year":"2021","unstructured":"Liu L, Xie S, Teng YX, et al. Outcomes of liver resection for metabolic dysfunction-associated fatty liver disease or chronic hepatitis B-related HCC. Front Oncol. 2021;11: 783339","journal-title":"Front Oncol"},{"issue":"11","key":"11151_CR21","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1111\/jgh.15026","volume":"35","author":"JS Yoon","year":"2020","unstructured":"Yoon JS, Lee HY, Chung SW, et al. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma. J Gastroenterol Hepatol. 2020;35(11):1960\u20131968","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"11151_CR22","doi-asserted-by":"publisher","first-page":"18027","DOI":"10.1038\/s41598-025-03244-9","volume":"15","author":"KG Xiong","year":"2025","unstructured":"Xiong KG, Lin TS, Lin QB, et al. Impact of metabolic dysfunction-associated fatty liver disease on survival outcomes in patients undergoing radical resection for hepatitis B virus-related hepatocellular carcinoma. Sci Rep. 2025;15(1):18027. https:\/\/doi.org\/10.1038\/s41598-025-03244-9","journal-title":"Sci Rep"},{"key":"11151_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080684","author":"YP Lin","year":"2021","unstructured":"Lin YP, Lin SH, Wang CC, et al. Impact of MAFLD on HBV-related stage 0\/A hepatocellular carcinoma after curative resection. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11080684","journal-title":"J Pers Med"},{"issue":"9","key":"11151_CR24","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.62347\/LJRG3048","volume":"14","author":"CN Huynh","year":"2024","unstructured":"Huynh CN, Tsai YC, Tsai MJ, et al. Impact of concurrent MASLD on early-stage HCC following curative resection in chronic hepatitis B. Am J Cancer Res. 2024;14(9):4567\u20134579. https:\/\/doi.org\/10.62347\/LJRG3048","journal-title":"Am J Cancer Res"},{"key":"11151_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S577506","author":"YW Liu","year":"2026","unstructured":"Liu YW, Wang CC, Liu YW, Li WF, Yen YH, Kuo YH, et al. Concurrent steatotic liver disease and prognosis after curative resection of hepatocellular carcinoma. J Hepatocell Carcinoma. 2026. https:\/\/doi.org\/10.2147\/JHC.S577506","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"11151_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0586-4","volume":"12","author":"D Wang","year":"2019","unstructured":"Wang D, Zhu Y, Tang J, et al. Integrative molecular analysis of metastatic hepatocellular carcinoma. BMC Med Genomics. 2019;12(1): 164","journal-title":"BMC Med Genomics"},{"issue":"3","key":"11151_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","volume":"71","author":"J Calderaro","year":"2019","unstructured":"Calderaro J, Ziol M, Paradis V, Zucman-Rossi J. Molecular and histological correlations in liver cancer. J Hepatol. 2019;71(3):616\u2013630","journal-title":"J Hepatol"},{"issue":"12","key":"11151_CR28","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/bjs\/znad216","volume":"110","author":"P Arntz","year":"2023","unstructured":"Arntz P, Olthof PB. Assessment of liver function before major hepatectomy. Br J Surg. 2023;110(12):1588\u20131589. https:\/\/doi.org\/10.1093\/bjs\/znad216","journal-title":"Br J Surg"},{"key":"11151_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.10.026","author":"S Zhang","year":"2025","unstructured":"Zhang S, Xu H, Li M, et al. An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC. J Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.026","journal-title":"J Hepatol"},{"issue":"3","key":"11151_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12072-025-10801-x","volume":"19","author":"MCC Cheah","year":"2025","unstructured":"Cheah MCC, Crane H, George J. Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis. Hepatol Int. 2025;19(3):607\u2013618","journal-title":"Hepatol Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11151-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:10:50Z","timestamp":1792012250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11151-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":30,"alternative-id":["11151"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11151-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have not disclosed any competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Second Affiliated Hospital of Guangxi Medical University (No. 2021-KY-0398). The research protocol was approved by the institutional review committee of the participating center. In accordance with national legislation and institutional requirements, a written informed consent form for participation is not necessary for this study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}